Catalog Number 11776193122 |
Device Problem
Incorrect Or Inadequate Test Results (2456)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 05/26/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
This event occurred in (b)(6).
|
|
Event Description
|
The customer stated that they received erroneous results for one patient sample tested for carbohydrate antigen 19-9 (ca 19-9) on an elecsys analyzer.It was asked, but it is not known if any erroneous results were reported outside of the laboratory.The sample initially resulted as 241.5 u/ml.When diluted times 5, the sample resulted as 703.4 u/ml.When diluted times 10, the sample resulted as 1110.0 u/ml.The sample results were said to be non-linear.The patient was not adversely affected.The elecsys analyzer model and serial number were asked for, but not provided.
|
|
Manufacturer Narrative
|
The patient has a history of gastric polyp.The patient sample was provided for investigations where it was tested on a cobas 8000 analyzer.The sample resulted as 230.0 u/ml when run on the cobas 8000 analyzer.The sample was manually diluted times 2, resulting with a raw value 180.3 u/ml and resulting with a final value of 361 u/ml when accounting for the dilution factor.The sample was manually diluted times 5, resulting with a raw value 138.3 u/ml and resulting with a final value of 692 u/ml when accounting for the dilution factor.The sample was manually diluted times 10, resulting with a raw value 101.2 u/ml and resulting with a final value of 1012 u/ml when accounting for the dilution factor.When the sample was tested for neuraminidase recovery, it resulted as 230.5 u/ml before ca 19-9 and as 1.22 u/ml after ca 19-9.The sample was diluted times 10 and tested for neuraminidase recovery where it resulted as 103.6 u/ml before ca 19-9 and as 1.38 u/ml after ca 19-9.The cobas 8000 analyzer used in investigations was serial number (b)(4).Ca 19-9 reagent lot number 188632, with an expiration date of may 2017 was used on this analyzer.
|
|
Manufacturer Narrative
|
Investigations conclude that non linear dilution behavior of the sample could be verified.The ca 19-9 antigen tends to aggregate and this may lead to non linear dilution behavior in certain samples.This limitation is covered in product labeling.
|
|
Search Alerts/Recalls
|